Conceived and designed the experiments: JWC RJB. Performed the experiments: JWC SLS LL BJM. Analyzed the data: JWC GLE BJM HRB TEH MJY RJB. Contributed reagents/materials/analysis tools: SLS LL. Wrote the paper: JWC GLE BJM MJY RJB.
Osteogenesis Imperfecta (OI) is a human syndrome characterized by exquisitely fragile bones due to osteoporosis. The majority of autosomal dominant OI cases result from point or splice site mutations in the type I collagen genes, which are thought to lead to aberrant osteoid within developing bones. OI also occurs in humans with homozygous mutations in Prolyl-3-Hydroxylase-1 (LEPRE1). Although P3H1 is known to hydroxylate a single residue (pro-986) in type I collagen chains, it is unclear how this modification acts to facilitate collagen fibril formation. P3H1 exists in a complex with CRTAP and the peptidyl-prolyl isomerase cyclophilin B (CypB), encoded by the
Osteogenesis Imperfecta (OI), also known as “brittle bone disease,” is an inherited condition with multiple defects in collagen-containing structures, including the bones, skin, and other connective tissues. Patients with OI suffer from short stature, scoliosis, thin skin, hearing loss, and, most notably, fragile bones that break with little or no trauma. Although many cases are due to dominantly inherited point mutations in the collagen genes, autosomal recessive forms have been described due to defects in the genes for Prolyl-3-Hydroxylase-1 (LEPRE1) and Cartilage-Associated Protein (CRTAP), proteins that modify newly synthesized procollagen. Some patients with OI do not have mutations in any of the known disease-related genes. Here, through the use of newly generated knockout mice, we identify the endoplasmic-reticulum resident prolyl-isomerase cyclophilin B (CypB) as a new autosomal recessive OI gene in mice. CypB, P3H1, and CRTAP were shown to have interrelated effects in maintaining their respective protein levels and ability to bind to collagen. These studies enhance our understanding about how collagen, the most abundant protein in the body, becomes properly assembled to form bones with adequate strength.
OI is an inherited disorder of collagen, affecting one in 12,000 newborns
Cyclophilins form a class of proteins originally discovered by virtue of their high specific affinity for the immunosuppressant drug cyclosporin A
Cyclophilin B (CypB) is a highly related family member that is present within the endoplasmic reticulum (ER) of all cell types
An important feature of patients with OI is the high degree of variability in the severity of their disease symptoms. The causes for this variability are not understood, however it is likely that there are unlinked modifier genes that impact the phenotypic spectrum of disease severity
To determine the role of CypB in vivo, we targeted exon 3 by homologous recombination, and generated mice bearing the knockout allele (
(A) The third exon of the
Because CypB is expressed in all cell types, and is highly conserved from yeast to humans, we anticipated that homozygous loss might cause developmental abnormalities during embryogenesis. Surprisingly, CypB knockout mice appeared normal at birth, and both sexes were fertile. In addition,
(A) Total body radiographs of 38-week-old mice. Note the enhanced curvature of the spine in the
To study the pathophysiology of altered bone development,
Because of the critical role for collagen in directing bone formation
(A) Skin fibroblasts from wild-type or CypB knockout mice were cultured in serum free medium. Secreted collagen from the supernatant was electropheresed on 5% SDS-PAGE and detected by Western Blotting. Type I collagen from mutant animals demonstrated a subtle but reproducible decrease in migration compared to wild type. (B) Mass-spectroscopic analysis of type I and type II collagen from bone and cartilage. Chromatogram of the parent ions in the mass spectra from wild type and
Samples of bone and cartilage were extracted by limited pepsin digestion, and proteins resolved by SDS-PAGE. Coomassie blue stained bands were excised, subjected to trypsinization, and analyzed by tandem mass spectrometry. The tryptic peptide containing proline-986 (975-DGLNGLPGPIG
3-hydroxylation of Pro-986 in type I collagen is required for correct fibril formation because mutation of P3H1 or CRTAP causes the accumulation of aberrant fibrils with wider than normal diameter
MEFs prepared from wild-type (WT) or CypB knockout mice (KO) were cultured with or without 24hr stimulation with ascorbic acid (+AS). Cells were fixed, permeabilized, and co-stained for intracellular collagen and the Golgi marker GM130 (A) or the ER-resident protein PDI (B). (bar = 40 µm).
Thin skin is a common feature of patients with OI. We noticed that CypB −/− mice were easily identified by their loose skin (
(A) Typical appearance of wild-type (left) and
Lastly, we prepared collagen from skin samples, and analyzed it by mass spectroscopy. As described for bone and cartilage collagen, there was a severe loss of triple-hydroxylated collagen representing the 986-hydroxylated peptide (
Several other investigators have reported that CypB is able to bind to collagen, and to the P3H1 / CRTAP complex
(A) GST-cyclophilin B or GST was mixed and pulled down with gelatin sepharose in the absence or presence of cyclosporine A. Proteins were visualized by blotting with antibody to GST. (B) Lysates from wild type cells were mixed with recombinant GST-cyclophilin B or GST, and bound proteins isolated using GSH-agarose prior to SDS PAGE. Proteins were visualized by western blotting with antibodies to the indicated proteins. (C) Binding of GST-CypB to P3H1 in lysates from wild-type (WT) or CypB-knockout fibroblasts (KO) was detected by chromatography on glutathione-agarose followed by western blotting for P3H1. Although P3H1 is present at much lower levels in the absence of CypB, a greater fraction of it binds to recombinant CypB in vitro. (D) Western blot of the indicated proteins from lysates of wild-type and CypB knockout skin fibroblasts. Blotting for beta-actin was performed as a loading control. (E) Proteins from lysates of wild-type and CypB–knockout skin fibroblasts were isolated on gelatin-sepharose. Bound proteins were eluted and detected by western blotting with antibodies to the indicated proteins.
We investigated whether recombinant CypB would also bind to P3H1 from cells. Lysates from wild type fibroblasts were prepared, incubated with the fusion protein, and then passed over glutathione-agarose resin to recover GST-CypB. We observed a moderate degree of retention of P3H1 specifically to GST-CypB, and none to GST alone, indicating they may indeed interact. (
In conducting these studies, we also found that the amount of P3H1 was relatively reduced in CypB-deficient cells (
To investigate the reciprocal relationship of P3H1 effects on CypB, several commercial shRNA lentivirus preparations were tested, and two were found to cause significant depletion of P3H1 protein in murine fibroblasts. We found that in both cases, reduction of P3H1 did not have any effect on intracellular levels of CypB (
(A) Mouse fibroblasts were transduced with two different shRNA lentiviruses (#65 and #67) to knockdown P3H1 or a control lentivirus (“C”). Lysates were mixed with gelatin-sepharose to adsorb collagen binding proteins, and then recovered for western blotting, as indicated. Total cellular levels of CypB were not affected by knockdown of P3H1, however binding to gelatin was reduced. (B) As described in (A) in the absence or presence (“AS”) of ascorbic acid in the medium. (C) HeLa cells were transduced with a CypB specific shRNA lentivirus or control and lysates probed for gelatin-binding proteins as described. Knockdown of CypB did not affect CRTAP levels or binding to gelatin. (D) Knockdown of CRTAP in HeLa cells reduced P3H1 cellular levels and blocked the binding of CypB to gelatin in vitro.
Like P3H1, CRTAP has been reported to be mutated in mice and humans with OI. CRTAP does not have a known enzymatic function, and, although collagen from CRTAP−/− mice was shown to have reduced prolyl–3-hydroxylation, its mechanism in this process is not understood. Unfortunately, we were unable to obtain antibodies that recognized the murine CRTAP, thus we turned to a human cell system to explore its potential interactions. HeLa cells were found to have easily detectable CRTAP. CypB was knocked down using a shRNA lentivirus, and lysates were tested as described above. Although CypB was efficiently reduced, there was no impairment of either CRTAP accumulation, nor of the binding of CRTAP to gelatin-sepharose (
Knockdown of CRTAP in HeLa cells, on the other hand, caused a substantial depletion of P3H1 (
Collagen makes up the most abundant protein in the body, and is critically important for structural elements of skin and subcutaneous tissue, as well as for providing the osteoid framework on which calcium phosphate precipitates during bone formation. The problem of how microscopic cells synthesize and properly build structures, such as bones, that are many orders of magnitude larger than themselves is an important one in biology and medicine, however the details of this complex process are incompletely understood. It has been of great value to study human and mouse mutants with abnormal bone development, like OI, in order to identify the critical components of this system.
Eight types of OI have been described
Cyclophilins form an ancient, highly conserved group of proteins that are present in all eukaryotic cells, and in some bacteria
Our molecular studies provide a framework for understanding the relatively complex interrelationships of the members of the P3H1/CRTAP/CypB complex. Intracellular levels of P3H1 were dependent upon both CypB and CRTAP individually. However, P3H1 did not require either partner in order to maintain its ability to bind stably to collagen in the form of gelatin-sepharose. Others have previously shown that the prolyl-3-hydroxylation reaction of P3H1 in the absence of partner proteins is intact
On the other hand, although intracellular levels of CypB did not depend upon either CRTAP or P3H1, knockdown of either significantly prevented the binding of CypB to gelatin-sepharose. Although CypB has an endogenous collagen-binding property, we observed that the extent of binding is relatively low. CypB in complex with P3H1 was a much better substrate for affinity to gelatin-sepharose. One conclusion from these studies is the observation that in each condition that can cause OI (i.e. loss of any member of the P3H1/CRTAP/CypB complex), there is a significant loss of CypB binding to collagen (
P3H1 not only hydroxylates the 3 position of proline 986, but also plays a key role by facilitating the binding of CypB to collagen within the ER. In all 3 conditions that lead to OI, P3H1 hydroxylation is absent, and CypB binding to collagen is reduced or absent.
Alternative mechanisms for CypB are possible, however. Others have shown that abnormally folded collagen is degraded by proteasomes, which reside in the cytosol, thus would require retrotranslocation
As noted above, there are some OI patients that do not have identified disease mutations. Our results suggested to us the possibility that CypB might be a potential underlying cause in a subset of these people. Indeed, while this manuscript was in revision, several humans with recessive OI of the severe neonatal type were reported to have mutations in the
Cyclosporin A is a commonly used immunosuppressant. It works by binding to cyclophilin A, which then blocks the interaction of calcineurin with its downstream target NFAT
All animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee. A targeting plasmid was generated using a BAC clone containing the entire
Mouse embryonic fibroblasts (MEFs) or skin fibroblasts were generated as previously described
Mice were euthanized and analyzed by radiography (GE AMX 4) of whole body or hind limbs. The femur was cleaned of soft tissue and measured ex-vivo on a uCT 35 micro-CT scanner (Scanco Medical, Basserdorf,Switzerland). Trabecular architecture was measured distally from the growth plate (70 kVP, increment 7 um) at a resolution of 7 um. The analysis region was represented by 100 slices.
To analyze modification of secreted procollagen, confluent fibroblasts were stimulated in serum-free conditions containing ascorbate during the 48 hrs. The harvested media were electrophoresed on 5% SDS polyacrylamide gels under reducing conditions and processed for westernblotting with type I collagen antibody (SouthernBioTech). To examine the overall architecture and quantify the collagen content in a given area of mouse skin tissue, sections of paraffin-embedded skin sample from abdomen were stained with H&E or Picrosirius red (Polysciences, Inc.). Type I collagen in the extract from skin samples was quantified with Mouse Type I Collagen Detection Kit (Chondrex, Inc.)
To determine prolyl 3-hydroxylation in collagen samples from skin, bone and cartilage, collagen was solubilized and extracted by a limited digestion with pepsin (100 µg/ml; Calbiochem) in 0.5N acetic acid for 48 hr. This extracts were resolved by SDS-PAGE. For collagen samples obtained from skin fibroblast culture, the harvested culture media were concentrated by Centricon (Millipore) and resolved by SDS-PAGE. The Coomassie Blue stained SDS-PAGE gel bands were prepared for mass spectrometry analysis using the following procedures. The gel bands were destained with 50 mM Tris, pH 8.1/50% acetonitrile until nearly clear. The bands were then reduced with 30 mM DTT/50 mM Tris, pH 8.1 at 55°C for 40 minutes and alkylated with 40 mM iodoacetamide at room temperature for 40 minutes in the dark. Proteins were digested in-situ with 30 ul (0.004 ug/ul) trypsin (Promega Corporation, Madison WI) in 20 mM Tris pH 8.1/.0002% Zwittergent 3–16, at 37°C overnight followed by peptide extraction with 60 ul of 2% trifluoroacetic acid, then 60 ul of acetonitrile. The pooled extracts were concentrated to less than 5 ul on a SpeedVac spinning concentrator (Savant Intruments, Holbrook NY) and then brought up in 0.15% formic acid/0.05% trifluoroacetic acid for protein identification by nano-flow liquid chromatography electrospray tandem mass spectrometry (nanoLC-ESI-MS/MS) using a ThermoFinnigan LTQ Orbitrap Hybrid Mass Spectrometer (ThermoElectron Bremen, Germany) coupled to an Eksigent nanoLC-2D HPLC system (Eksigent, Dublin, CA). The digest peptide mixture was loaded onto a 250nl OPTI-PAK trap (Optimize Technologies, Oregon City, OR) custom packed with Michrom Magic C8 solid phase (Michrom Bioresources, Auburn, CA). Chromatography was performed using 0.2% formic acid in both the A solvent (98%water/2%acetonitrile) and B solvent (80% acetonitrile/10% isopropanol/10% water), and a 5%B to 45%B gradient over 60 minutes at 400 nl/min through a Michrom packed tip capillary Magic C18 75 µm x 200 mm column. The initial LTQ Orbitrap mass spectrometer experiment was set to perform a FT full scan from 375–1600 m/z with resolution set at 60,000 (at 400 m/z), followed by linear ion trap MS/MS scans on the top five ions. Dynamic exclusion was set to 2 and selected ions were placed on an exclusion list for 40 seconds. The lock-mass option was enabled for the FT full scans using the ambient air polydimethylcyclosiloxane (PCM) ion of m/z = 445.120024 or a common phthalate ion m/z = 391.284286 for real time internal calibration.
The experiment to target the hydroxyproline sites of the peptide DGLNGLPGPIGPPGPR, relied on performing MS3 on the abundant y-ion from fragmentation N-terminal to a proline residue. The Orbitrap full scan used a list of masses for the [M+2H]2+ ions of this peptide without and with 1 to 5 hydroxyprolines to trigger the data dependant ion trap MS/MS scans. The ion trap MS/MS/MS scans were triggered on the most abundant ion of the MS/MS scan. If no masses from the list were detected in the Orbitrap full scan, then the most abundant ions triggered the MS/MS events.
The MS/MS raw data were converted to DTA files using extract_msn.exe from Bioworks 3.2 and correlated to theoretical fragmentation patterns of tryptic peptide sequences from the Swissprot databases using Mascot™ 2 (Matrix Sciences London, UK). All searches were conducted with fixed modification of carbamidomethyl-cysteine and variable modifications allowing oxidation of methionines for methione sulphoxide, oxidation of prolines for hydroxyproline, and protein N-terminal acetylation. The search was restricted to full trypsin generated peptides allowing for 2 missed cleavages and was left open to all species. Peptide mass search tolerances were set to 10 ppm and fragment mass tolerances are set to±0.8 Daltons. All protein identifications were considered when Mascot individual peptide scores were above the 95% percentile for probability and rank number one of all the hits for the respective MS/MS spectra. The MS/MS/MS scans were analyzed manually.
Skin tissues taken from lower abdomen were processed for transmission electron microscopy as described
MEFs were cultured on coverslides, fixed with 2.5% paraformaldehyde in PBS and permeabilized using 0.2% Triton X-100 in PBS for 2 min. Cells were blocked with PBS containing 5% goat serum and stained for intracellular collagen with anti-mouse collagen antibody (AB765P; Chemicon). Cellular localization was verified by costaining with anti-PDI (stressgen) or anti-GM130 antibody (BD). Samples were visualized using a Zeiss epifluorescence microscope.
Cells were lysed in 1% NP-40, 20 mM HEPES [pH 7.4], 5 mM NaCl, 5 mM MgCl2, 1 mM EGTA, 1 mM EDTA, 1 mM PMSF, 10 µg/ml leupeptin, and 45 µg/ml aprotinin. 50 µg of protein lysates were resolved by 8% SDS-PAGE and transferred to charged nylon membranes (Millipore). Western blots were probed for cyclophilin B with rabbit polyclonal antibody (Affinity BioReagents) or mouse monoclonal antibody (k2E2; Abcam), type I collagen (SouthernBioTech), P3H1 (Abnova), PDI (Stressgen), Hsp47 (Stressgen), FKBP65 (BD), GST (Sigma), CRTAP (Abnova) and beta-actin (Sigma). Reactive bands were visualized with a secondary antibody conjugated with HRP (Zymed) and chemiluminescence (Thermo scientific). For pulldowns, cell extracts were mixed with GST-cyclophilin B or GST and treated with GSH-agarose (GE healthcare), washed in lysis buffer and eluted by SDS sample buffer. For binding assays with gelatin-sepharose (GE healthcare), lysates containing approximately 1 mg of total protein were mixed with gelatin-sepharose for 3 h at 4°C with continuous rotation. The resulting precipitate was washed twice with lysis buffer, subjected to SDS-PAGE, and then blotted for the indicated protein.
Total RNA was purified with TRIZOL (Invitrogen) from splenocytes or MEFs and used as a template for synthesis of cDNA with SuperScript III First Strand RT-PCR kit (Invitrogen). With TaqMAN Gene Expression Assays (Applied Biosystems),
Skin from 38-weeks old female mice was biomechanically tested for tensile strength as described
(A) Western blot of lysates from splenocytes (left) and MEFs (right) using two different antibodies to verify absence of immunoreactive CypB in knockout cells. (B) Real time rtPCR of CypB mRNA normalized to actin message levels in splenocytes from wildtype or knockout animals.
(1.19 MB TIF)
Click here for additional data file.
Radiographs. (A) Total body radiographs showing the skeletons of mice at 24 and 63 weeks of age. Bar = 1 cm. (B) Radiographs of lower limbs. The measured ratios of femur to tibia were similar in all mice, regardless of CypB.
(1.86 MB TIF)
Click here for additional data file.
MS2 and MS3 analysis of peptides from bone, demonstrating the data used for identification of hydroxylated proline residues.
(1.95 MB TIF)
Click here for additional data file.
Ion-current LC profile of the type I collagen tryptic peptides containing residue pro-986 from skin of wild type and knockout mice.
(0.62 MB TIF)
Click here for additional data file.
We thank the Mayo Clinic Bone Histomorphometry Core, the Mayo Clinic Mass Spectroscopy Core, and the Mayo Clinic Material and Structural Testing Core facilities for their support.
The authors have declared that no competing interests exist.
This work was supported by the Joseph Bloom Childrens Research Fund and the Stanley and Belle Bestor Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.